ALKS
Alkermes plc
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
48.32
▲ 0.30 (0.62%)
MARKET · —
Price
Open
48.02
Prev close
48.02
Day high
48.67
Day low
47.33
Volume
830.60K
Market cap
$8.11B
P/E (TTM)
127.18
52W range
25.17 – 55.67
Trailing performance
Returnvs SPY
1W
-1.49%
-0.1%
1M
-8.76%
-12.5%
3M
+30.80%
+27.7%
6M
+51.46%
+40.4%
YTD
+72.73%
+60.4%
1Y
+66.83%
+46.8%
3Y
+66.71%
-7.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$8.11B
Enterprise value$9.02B
Revenue (TTM)$1.67B
Gross profit$1.45B
EBITDA$284.93M
Net income$66.12M
EPS (TTM)$0.38
Free cash flow$153.38M
Total cash$656.58M
Total debt$1.57B
Book value / share$10.80
Shares outstanding167.76M
Float155.19M
Short % of float11.90%
Dividend yield—
Beta (5Y)0.27
Valuation & profitability ratios
Trailing P/E127.18
Forward P/E26.44
PEG ratio1.96
Price / sales—
Price / book4.48
EV / revenue5.41
EV / EBITDA31.67
Gross margin87.18%
Operating margin15.50%
Profit margin3.96%
Return on equity3.85%
Return on assets4.20%
Debt / equity86.95
Current ratio2.30
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.48B | $1.56B | $1.66B | $1.11B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $241.66M | $367.07M | $355.76M | -$158.27M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $241.66M | $367.07M | $355.76M | -$158.27M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.29 | 0.70 | +141.3% |
| Mar 2026 | -0.04 | 0.38 | +1,053.0% |
| Dec 2025 | 0.45 | 0.48 | +7.7% |
| Sep 2025 | 0.39 | 0.65 | +68.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.25 | 4 | $465.57M | +18.1% |
| Next quarter | 0.09 | 4 | $473.38M | +23.1% |
| Current year | 1.27 | 4 | $1.82B | +23.7% |
| Next year | 1.83 | 4 | $1.94B | +6.6% |
Analyst targets & ownership
Mean target$56.00
High target$72.00
Low target$38.00
Implied upside15.89%
Analyst count17
ConsensusBUY
Strong buy / Buy3 / 11
Hold3
Sell / Strong sell0 / 1
Held by insiders1.40%
Held by institutions108.78%
Institutions holding578
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+61.34K
Net buying
Buy transactions
28
212.74K shares
Sell transactions
18
151.39K shares
Net transactions
+46
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
2.36M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | NICHOLS CHRISTIAN TODD Officer |
SELL | 7.58K | $372.94K | Direct |
| Aug 3, 26 | HOPKINSON CRAIG C Officer |
CONVERSION | 5.00K | $122.40K | Direct |
| Aug 3, 26 | SNYDERMAN NANCY LYNN Director |
CONVERSION | 44.47K | $2.08M | Direct |
| Aug 3, 26 | HOPKINSON CRAIG C Officer |
SELL | 9.00K | $437.22K | Direct |
| Aug 3, 26 | SNYDERMAN NANCY LYNN Director |
SELL | 44.47K | $2.24M | Direct |
| Aug 3, 26 | GAFFIN DAVID JOSEPH Officer |
SELL | 2.03K | $98.81K | Direct |
| Jul 6, 26 | GAFFIN DAVID JOSEPH Officer |
SELL | 2.03K | $109.90K | Direct |
| Jul 1, 26 | HOPKINSON CRAIG C Officer |
CONVERSION | 5.00K | $96.70K | Direct |
| Jul 1, 26 | HOPKINSON CRAIG C Officer |
SELL | 9.00K | $463.62K | Direct |
| Jun 12, 26 | WRIGHT CHRISTOPHER I Director |
SELL | 2.00K | $90.20K | Direct |
| Jun 4, 26 | GAFFIN DAVID JOSEPH Officer |
SELL | 2.03K | $87.56K | Direct |
| Jun 1, 26 | HOPKINSON CRAIG C Officer |
CONVERSION | 5.00K | $96.70K | Direct |
| Jun 1, 26 | HOPKINSON CRAIG C Officer |
SELL | 9.00K | $375.04K | Direct |
| May 29, 26 | PARISI SAMUEL JOSEPH Officer |
CONVERSION | 16.22K | $315.98K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROWN IAIN MICHAEL |
Chief Financial Officer | 148.20K | Conversion of Exercise of derivative security |
COOKE SHANE M |
Director | 106.68K | Conversion of Exercise of derivative security |
GAFFIN DAVID JOSEPH |
Officer | 225.46K | Sale |
HOPKINSON CRAIG C |
Officer | 69.39K | Conversion of Exercise of derivative security |
JACKSON BLAIR CURTIS |
Chief Operating Officer | 241.31K | Conversion of Exercise of derivative security |
MCKEON BRIAN P |
Director | 48.54K | Conversion of Exercise of derivative security |
NICHOLS CHRISTIAN TODD |
Officer | 102.19K | Sale |
POPS RICHARD F |
Chief Executive Officer | 1.38M | Stock Award(Grant) |
SNYDERMAN NANCY LYNN |
Director | 36.18K | Conversion of Exercise of derivative security |
WILSON FRANK ANDERS |
Director | 35.75K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
49.33
-2.04% from price
SMA 20
49.51
-2.38% from price
SMA 50
50.29
-3.90% from price
SMA 100
43.47
+11.17% from price
SMA 200
36.89
+31.03% from price
EMA 12
49.31
-2.00% from price
EMA 26
49.66
-2.70% from price
EMA 50
48.45
-0.27% from price
RSI (14)
43.6
Neutral
MACD (12,26,9)
-0.35
Hist -0.18
ATR (14)
1.64
3.39% of price
Realised vol 30D
30.2%
Annualised
Bollinger upper
51.50
20, 2σ
Bollinger lower
47.52
20, 2σ
50 / 200 cross
Golden
50.29 vs 36.89
Trend bias
Above 200
+31.03%
Risk profile
Beta vs SPY
0.77
Less volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
30.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.2%
Peak to trough
Max drawdown 5Y
-33.2%
Peak to trough
ATR 14
1.64
3.39% of price
Beta (reported)
0.27
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.76
Put-heavy session
Put / call open interest
1.07
Positioning, not flow
Max pain
50.00
+3.5% from spot
ATM implied vol
44.1%
Nearest strike to spot
Skew (10% OTM)
-11.4%
Calls bid over puts
Call volume
88
Contracts, this expiry
Put volume
155
Contracts, this expiry
Heaviest call OI
50.00
127 contracts
Heaviest put OI
50.00
96 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Zacks · 22h ago
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Zacks · 24h ago
ALKS Stock Rises 27% in 3 Months: Here's What You Should Know
Zacks · 10d ago
Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure?
Insider Monkey · 11d ago
The Race to Come Up With the Next Big Sleep Drug
The Wall Street Journal · 16d ago
Alkermes Insider Sold Shares Worth $2,239,076, According to a Recent SEC Filing
MT Newswires · 18d ago
Is Alkermes (ALKS) Priced For Orexin Success Or Too Rich?
Simply Wall St. · 21d ago
Alkermes (ALKS) Reported Mixed Q2 Results, Does It Look Fairly Valued?
Simply Wall St. · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.